Management of post-transplant lymphoproliferative disorder in adult solid organ transplant recipients - BCSH and BTS Guidelines

British Journal of Haematology

Volumn 149, Issue 5, 2010, Pages 693-705

  Parker, Anne ^a,j   Bowles, Kristin ^b   Bradley, J Andrew ^c   Emery, Vincent ^d   Featherstone, Carrie ^a   Gupte, Girish ^e   Marcus, Robert ^f   Parameshwar, Jayan ^g   Ramsay, Alan ^h   Newstead, Charles ⁱ  

^a BEATSON WEST OF SCOTLAND CANCER CENTRE   (United Kingdom)

^b NORFOLK AND NORWICH HOSPITAL   (United Kingdom)

^c ADDENBROOKE S HOSPITAL   (United Kingdom)

^d ROYAL FREE HOSPITAL   (United Kingdom)

^e BIRMINGHAM CHILDREN S HOSPITAL   (United Kingdom)

^f KING S COLLEGE HOSPITAL   (United Kingdom)

^g PAPWORTH HOSPITAL   (United Kingdom)

^h UNIVERSITY COLLEGE HOSPITAL   (United Kingdom)

ⁱ ST JAMES S UNIVERSITY HOSPITAL   (United Kingdom)

^j British Society for Haematology   (United Kingdom)

more..

Author keywords

Chemotherapy; Lymphoproliferative; Therapy; Transplant

Indexed keywords

ALKYLATING AGENT; ANTINEOPLASTIC AGENT; AZATHIOPRINE; B LYMPHOCYTE ANTIBODY; BLEOMYCIN; CD20 ANTIBODY; CHLORAMBUCIL; CISPLATIN; CYCLOPHOSPHAMIDE; CYCLOSPORIN A; CYTARABINE; DACARBAZINE; DOXORUBICIN; ETOPOSIDE; FLUDARABINE; GEMCITABINE; GRANULOCYTE COLONY STIMULATING FACTOR; IFOSFAMIDE; METHOTREXATE; MITOXANTRONE; MYCOPHENOLIC ACID; PREDNISOLONE; PREDNISONE; PROCARBAZINE; RITUXIMAB; STEROID; TACROLIMUS; UNINDEXED DRUG; VINBLASTINE; VINCRISTINE;

ADOPTIVE IMMUNOTHERAPY; B CELL LYMPHOMA; BURKITT LYMPHOMA; CANCER COMBINATION CHEMOTHERAPY; CANCER RADIOTHERAPY; CLINICAL TRIAL; COMPUTER ASSISTED EMISSION TOMOGRAPHY; COMPUTER ASSISTED TOMOGRAPHY; CYTOREDUCTIVE SURGERY; DRUG EFFICACY; DRUG MEGADOSE; DRUG RESPONSE; DRUG TOLERABILITY; FEBRILE NEUTROPENIA; FOLLICULAR LYMPHOMA; GRAFT RECIPIENT; GRAFT REJECTION; HODGKIN DISEASE; HUMAN; IMMUNOSUPPRESSIVE TREATMENT; LAPAROTOMY; LARGE CELL LYMPHOMA; LUNG TRANSPLANTATION; LYMPHOMA; LYMPHOPROLIFERATIVE DISEASE; MONOTHERAPY; MUCOSA ASSOCIATED LYMPHOID TISSUE LYMPHOMA; ORGAN TRANSPLANTATION; POSTOPERATIVE PERIOD; PRIMARY CENTRAL NERVOUS SYSTEM LYMPHOMA; PRIORITY JOURNAL; PROGNOSIS; REVIEW; RISK FACTOR; SCORING SYSTEM; T CELL LYMPHOMA; UNSPECIFIED SIDE EFFECT;

ADULT; ALGORITHMS; ANTIBODIES, MONOCLONAL; ANTINEOPLASTIC AGENTS; COMBINED MODALITY THERAPY; DRUG ADMINISTRATION SCHEDULE; EVIDENCE-BASED MEDICINE; HUMANS; IMMUNOSUPPRESSIVE AGENTS; IMMUNOTHERAPY, ADOPTIVE; LYMPHOPROLIFERATIVE DISORDERS; ORGAN TRANSPLANTATION; PROGNOSIS; REOPERATION;

EID: 77952630793     PISSN: 00071048     EISSN: 13652141     Source Type: Journal    
DOI: 10.1111/j.1365-2141.2010.08160.x     Document Type: Review

References (89)

1. Aull, M.J., Buell, J.F., Peddi, V.R., Trofe, J., Beebe, T.M., Hanaway, M.J., Roy-Chaudhury, P., Alloway, R.R., First, M.R., Woodle, E.S. Israel Penn International Transplant Tumor Registry (2003) MALToma: a Helicobacter pylori-associated malignancy in transplant patients: a report from the Israel Penn International Transplant Tumor Registry with a review of published literature. Transplantation, 75, 225 228.
2. Aull, M.J., Buell, J.F., Trofe, J., First, M.R., Alloway, R.R., Hanaway, M.J., Wagoner, L., Gross, T., Beebe, T. Woodle, E.S. (2004) Experience with 274 cardiac recipients with posttransplant lymphoproliferative disorder: a report from the Israel Penn International Transplant Tumor Registry. Transplantation, 78, 1676 1682.
3. Bates, W.D., Gray, D.W.R., Dada, M.A., Chetty, R., Gatter, K.C., Davies, D.R. Morris, P.J. (2003) Lymphoproliferative disorders in Oxford renal transplant recipients. Journal of Clinical Pathology, 56, 439 446.
4. Berney, T., Delis, S., Kato, T., Nishida, S., Mittal, N.K., Madariaga, J., Levi, D., Nery, J.R., Cirocco, R.E., Gelman, B., Ruiz, P. Tzakis, A.G. (2002) Successful treatment of posttransplant lymphoproliferative disease with prolonged rituximab treatment in intestinal transplant recipients. Transplantation, 74, 1000 1006.
5. Birkeland, S., Hamilton-Dutoit, S. Bendtzen, K. (2003) Long-term follow-up of kidney transplant patients with posttransplant lymphoproliferative disorder: duration of post-transplant lymphoproliferative disorder-induced operational graft tolerance, interleukin-18 course, and results of re-transplantation. Transplantation, 75, 153 158.
6. Blaes, A.H., Peterson, B.A., Bartlett, N., Dunn, D.L. Morrison, V.A. (2005) Rituximab therapy is effective for posttransplant lymphoproliferative disorders after solid organ transplantation: results of a phase II trial. Cancer, 104, 1661 1667.
7. Buadi, F.K., Heyman, M.R., Gocke, C.D., Rapoport, A.P., Hakimian, R., Bartlett, S.T. Sarkodee-Adoo, C. (2007) Treatment and outcomes of post-transplant lymphoproliferative disease: a single institution study. American Journal of Hematology, 82, 208 214.
8. Buell, J.F., Gross, T.G., Hanaway, M.J., Trofe, J., Roy-Chaudhury, P., First, M.R. Woodle, E.S. (2005) Posttransplant lymphoproliferative disorder: significance of central nervous system involvement. Transplantation Proceedings, 37, 954 955.
9. Campbell, P. Marcus, R. (2003) Monoclonal antibody therapy for lymphoma. Blood reviews, 17, 143 152.
10. Carbone, P.P., Kaplan, H.S., Musshoff, K., Smithers, D.W. Tubiana, M. (1971) Report of the Committee on Hodgkin's Disease Staging Classification. Cancer Research, 31, 1860 1861.
11. Chapchap, P., Carone, F.E., Porta, G., Miura, I., Zerbini, M., Gayotto, L. JG., M. (1991) Posttransplant lymphoproliferative disease of the liver successfully treated by retransplantation. Transplantation, 52, 736 737.
12. Chau, I., Harries, M., Cunningham, D., Hill, M., Ross, P.J., Archer, C.D., Norman, A.R., Wotherspoon, A., Koh, D.M., Gill, K., Uzzell, M., Prior, Y. Catovsky, D. (2003) Gemcitabine, cisplatin and methylprednisolone chemotherapy (GEM-P) is an effective regimen in patients with poor prognostic primary progressive or multiply relapsed Hodgkin's and non-Hodgkin's lymphoma. British Journal of Haematology, 120, 970 977.
13. Choquet, S., Leblond, V., Herbrecht, R., Socie, G., Stoppa, A.M., Vandenberghe, P., Fischer, A., Morschhauser, F., Salles, G., Feremans, W., Vilmer, E., Peraldi, M.N., Lang, P., Lebranchu, Y., Oksenhendler, E., Garnier, J.L., Lamy, T., Jaccard, A., Ferrant, A., Offner, F., Hermine, O., Moreau, A., Fafi-Kremer, S., Morand, P., Chatenoud, L., Berriot-Varoqueaux, N., Bergougnoux, L. Milpied, N. (2006) Efficacy and safety of rituximab in B-cell post-transplantation lymphoproliferative disorders: results of a prospective multicenter phase 2 study. Blood, 107, 3053 3057.
14. Choquet, S., Oertel, S., LeBlond, V., Riess, H., Varoqueaux, N., Dorken, B. Trappe, R. (2007) Rituximab in the management of post-transplantation lymphoproliferative disorder after solid organ transplantation: proceed with caution. Annals of Hematology, 86, 599 607.
15. Coiffier, B., Lepage, E., Briere, J., Herbrecht, R., Tilly, H., Bouabdallah, R., Morel, P., Van Den Neste, E., Salles, G., Gaulard, P., Reyes, F., Lederlin, P. Gisselbrecht, C. (2002) CHOP chemotherapy plus rituximab compared with CHOP alone in elderly patients with diffuse large-B-cell lymphoma. New England Journal of Medicine, 346, 235 242.
16. Comoli, P., Labirio, M., Basso, S., Baldanti, F., Grossi, P., Furione, M., Vigano, M., Fiocchi, R., Rossi, G., Ginevri, F., Gridelli, B., Moretta, A., Montagna, D., Locatelli, F., Gerna, G. Maccario, R. (2002) Infusion of autologous Epstein-Barr virus (EBV)-specific cytotoxic T cells for prevention of EBV-related lymphoproliferative disorder in solid organ transplant recipients with evidence of active virus replication. Blood, 99, 2592 2598.
17. Cook, R.C., Connors, J.M., Gascoyne, R.D., Fradet, G. Levy, R.D. (1999) Treatment of post-transplant lymphoproliferative disease with rituximab monoclonal antibody after lung transplantation. Lancet, 354, 1698 1699.
18. Davis, C. (2001) Interferon and cytotoxic chemotherapy for the treatment of post-transplant lymphoproliferative disorder. Transplation and Infectious Disease, 3, 108 118.
19. Davis, C., Wood, B., Sabath, D., Joseph, J., Stehman-Breen, C. Broudy, V. (1987) Interferon-alpha treatment of posttransplant lymphoproliferative disorder in recipients of solid organ transplants. Transplantation, 66, 1770 1779.
20. Delone, P., Corkill, J., Jordan, M., Krapiva, P., Ghasemian, R., Sasaki, T. Light, J. (1995) Successful treatment of Epstein-Barr virus infection with ganciclovir and cytomegalovirus hyperimmune globulin following kidney transplantation. Transplantation Proceedings, 27, 58 59.
21. Demircin, G. Rees, L. (1997) Retransplantation after post-transplant lymphoproliferative disease. Pediatric Nephrology, 11, 358 360.
22. Diehl, V., Stein, H., Hummel, M., Zollinger, R. Connors, J.M. (2003) Hodgkin's lymphoma: biology and treatment strategies for primary, refractory, and relapsed disease. Hematology, 2003, 225 247.
23. Dotti, G., Rambaldi, A., Fiocchi, R., Motta, T., Torre, G., Viero, P., Gridelli, B. Barbui, T. (2001) Anti-CD20 antibody (rituximab) administration in patients with late occurring lymphomas after solid organ transplant. Haematologica, 86, 618 623.
24. Dotti, G., Fiocchi, R., Motta, T., Mammana, C., Gotti, E., Riva, S., Cornelli, P., Gridelli, B., Viero, P., Oldani, E., Ferrazzi, P., Remuzzi, G., Barbui, T. Rambaldi, A. (2002) Lymphomas occurring late after solid-organ transplantation: influence of treatment on the clinical outcome. Transplantation, 74, 1095 1102.
25. Douglas, R.S., Goldstein, S.M., Katowitz, J.A., Gausas, R.E., Ibarra, M.S., Tsai, D., Sharma, A. Nichols, C. (2002) Orbital presentation of posttransplantation lymphoproliferative disorder: a small case series. Opthalmology, 109, 2351 2355.
26. EBPG Expert Group on Renal Transplantation (2002) European best practice guidelines for renal transplantation. Section IV: long-term management of the transplant recipient. IV.6.1. Cancer risk after renal transplantation. Post-transplant lymphoproliferative disease (PTLD): prevention and treatment. Nephrology Dialysis Transplantation, 17, 31 33, 35-36.
27. Elstrom, R.L., Andreadis, C., Aqui, N.A., Ahya, V.N., Bloom, R.D., Brozena, S.C., Olthoff, K.M., Schuster, S.J., Nasta, S.D., Stadtmauer, E.A. Tsai, D.E. (2006) Treatment of PTLD with rituximab or chemotherapy. American Journal of Transplantation, 6, 569 576.
28. Ferreri, A.J.M., Reni, M., Foppoli, M., Martelli, M., Pangalis, G.A., Frezzato, M., Cabras, M.G., Fabbri, A., Corazzelli, G., Ilariucci, F., Rossi, G., Soffietti, R., Stelitano, C., Vallisa, D., Zaja, F., Zoppegno, L., Aondio, G.M., Avvisati, G., Balzarotti, M., Brandes, A.A., Fajardo, J., Gomez, H., Guarini, A., Pinotti, G., Rigacci, L., Uhlmann, C., Picozzi, P., Vezzulli, P., Ponzoni, M., Zucca, E., Caligaris-Cappio, F. Cavalli, F. (2009) High-dose cytarabine plus high-dose methotrexate versus high-dose methotrexate alone in patients with primary CNS lymphoma: a randomised phase 2 trial. The Lancet, 374, 1512 1520.
29. Feugier, P., Van Hoof, A., Sebban, C., Solal-Celigny, P., Bouabdallah, R., Fermé, C., Christian, B., Lepage, E., Tilly, H., Morschhauser, F., Gaulard, P., Salles, G., Bosly, A., Gisselbrecht, C., Reyes, F. Coiffier, B. (2005) Long-term results of the R-CHOP study in the treatment of elderly patients with diffuse large B-cell lymphoma: a study by the Groupe d'Etude des Lymphomes de l'Adulte. Journal of Clinical Oncology, 23, 4117 4126.
30. Fohrer, C., Caillard, S., Koumarianou, A., Ellero, B., Woehl-Jaegle, M.L., Meyer, C., Epailly, E., Chenard, M.P., Lioure, B., Natarajan-Ame, S., Maloisel, F., Lutun, P., Kessler, R., Moulin, B., Bergerat, J.P., Wolf, P. Herbrecht, R. (2006) Long-term survival in post-transplant lymphoproliferative disorders with a dose-adjusted ACVBP regimen. British Journal of Haematology, 134, 602 612.
31. Foroncewicz, B., Mucha, K., Usiekniewicz, J., Chmura, A., Kryst, P., Sołdacki, D. Paczek, L. (2006) Posttransplant lymphoproliferative disorder of the lung in a renal transplant recipient treated successfully with surgery. Transplantation Proceedings, 38, 173 176.
32. Ghobrial, I.M., Habermann, T.M., Maurer, M.J., Geyer, S.M., Ristow, K.M., Larson, T.S., Walker, R.C., Ansell, S.M., Macon, W.R., Gores, G.G., Stegall, M.D. McGregor, C.G. (2005) Prognostic Analysis for Survival in Adult Solid Organ Transplant Recipients With Post-Transplantation Lymphoproliferative Disorders. Journal of Clinical Oncology, 23, 7574 7582.
33. Girinsky, T., Benhamou, E., Bourhis, J.-H., Dhermain, F., Guillot-Valls, D., Ganansia, V., Luboinski, M., Perez, A., Cosset, J.M., Socie, G., Baume, D., Bouaouina, N., Briot, E., Beaudre, A., Bridier, A. Pico, J.L. (2000) Prospective Randomized Comparison of Single-Dose Versus Hyperfractionated Total-Body Irradiation in Patients With Hematologic Malignancies. Journal of Clinical Oncology, 18, 981 986.
34. Gross, T.G., Bucuvalas, J.C., Park, J.R., Greiner, T.C., Hinrich, S.H., Kaufman, S.S., Langnas, A.N., McDonald, R.A., Ryckman, F.C., Shaw, B.W., Sudan, D.L. Lynch, J.C. (2005) Low-dose chemotherapy for Epstein-Barr virus-positive post-transplantation lymphoproliferative disease in children after solid organ transplantation. Journal of Clinical Oncology, 23, 6481 6488.
35. Haque, T., Wilkie, G.M., Taylor, C., Amlot, P.L., Murad, P., Iley, A., Dombagoda, D., Britton, K.M., Swerdlow, A.J. Crawford, D.H. (2002) Treatment of Epstein-Barr virus-positive post-transplant lymphoproliferative disease with partly HLA-matched allogeneic cytotoxic T cells. Lancet, 360, 436 441.
36. Haque, T., Wilkie, G.M., Jones, M.M., Higgins, C.D., Urquhart, G., Wingate, P., Burns, D., McAulay, K., Turner, M., Bellamy, C., Amlot, P.L., Kelly, D., MacGilchrist, A., Gandhi, M.K., Swerdlow, A.J. Crawford, D.H. (2007) Allogeneic cytotoxic T-cell therapy for EBV-positive posttransplantation lymphoproliferative disease: results of a phase 2 multicenter clinical trial. Blood, 110, 1123 1131.
37. Heim-Duthoy, K., Chitwood, K., Tortorice, K., Massy, Z. Kasiske, B. (1994) Elective cyclosporine withdrawal 1 year after renal transplantation. American Journal of Kidney Diseases, 24, 846 853.
38. Hsi, E.D., Singleton, T.P., Swinnen, L., Dunphy, C.H. Alkan, S. (2000) Mucosa-associated lymphoid tissue-type lymphomas occurring in post-transplantation patients. American Journal of Surgical Pathology, 24, 100 106.
39. Hsu, Y.C., Liao, W.C., Wang, H.P., Yao, M. Lin, J.T. (2009) Catastrophic gastrointestinal manifestations of post-transplant lymphoproliferative disorder. Digestive and Liver Disease, 41, 238 241.
40. Jaeger, G., Linkesch, W., Temmel, W. Neumeister, P. (2005) Anti CD20 monoclonal antibody-based radioimmunotherapy of relapsed chemoresistant aggressive posttransplant B-lymphoproliferative disorder in heart-transplant recipients. Lancet Oncology, 6, 629 631.
41. Jain, A.B., Marcos, A., Pokharna, R., Shapiro, R., Fontes, P.A., Marsh, W., Mohanka, R. Fung, J.J. (2005) Rituximab (chimeric anti-CD20 antibody) for posttransplant lymphoproliferative disorder after solid organ transplantation in adults: long-term experience from a single center. Transplantation, 80, 1692 1698.
42. Jenkins, D., DiFrancesco, L., Chaudhry, A., Morris, D., Glück, S., Jones, A., Woodman, R., Brown, C., Russell, J. Stewart, D. (2002) Successful treatment of post-transplant lymphoproliferative disorder in autologous blood stem cell transplant recipients. Bone Marrow Transplantation, 30, 321 326.
43. Johnson, S., Cherikh, W., Kauffman, H., Pavlakis, M. Hanto, D. (2006) Retransplantation after post-transplant lymphoproliferative disorders: an OPTN/UNOS database analysis. American Journal of Transplantation, 6, 2743 2749.
44. Kang, S.K., Kirkpatrick, J.P. Halperin, E.C. (2004) Low-dose radiation for posttransplant lymphoproliferative disorder. American Journal of Clinical Oncology, 26, 210 214.
45. Karras, A., Thervet, E., Le Meur, Y., Baudet-Bonneville, V., Kessler, M. Legendre, C. (2004) Successful renal retransplantation after post-transplant lymphoproliferative disease. American Journal of Transplantation, 4, 1904 1909.
46. Kollmar, O., Becker, S., Schilling, M.K. Maurer, C.A. (2002) Intestinal lymphoma perforations as a consequence of highly effective anti-CD20 antibody therapy. Transplantation, 73, 669 670.
47. Kwong, Y.L. (2005) Natural-killer cell malignancies: diagnosis and management. Leukaemia, 19, 2186 2194.
48. Kwong, Y.L., Lam, C.C.K. Chan, T.M. (2000) Post-transplantation lymphoproliferative disease of natural killer cell lineage: a clinicopathological and molecular analysis. British Journal of Haematology, 110, 197 202.
49. Leblond, V., Sutton, L., Dorent, R., Davi, F., Bitker, M.O., Gabarre, J., Charlotte, F., Ghoussoub, J.J., Fourcade, C. Fischer, A. (1995) Lymphoproliferative disorders after organ transplantation: a report of 24 cases observed in a single center. Journal of Clinical Oncology, 13, 961 968.
50. Leblond, V., Dhedin, N., Bruneel, M.-F.M., Choquet, S., Hermine, O., Porcher, R., Quoc, S.N., Davi, F., Charlotte, F., Dorent, R., Barrou, B., Vernant, J.-P., Raphael, M. Levy, V. (2001) Identification of Prognostic Factors in 61 Patients With Posttransplantation Lymphoproliferative Disorders. Journal of Clinical Oncology, 19, 772 778.
51. Libertiny, G., Watson, C.J., Gray, D.W., Welsh, K.I. Morris, P.J. (2001) Rising incidence of post-transplant lymphoproliferative disease in kidney transplant recipients. British Journal of Surgery, 88, 1330 1334.
52. Little, R., Pittaluga, S., Grant, N., Steinberg, S., Kavlick, M., Mitsuya, H., Franchini, G., Gutierrez, M., Raffeld, M., Jaffe, E., Shearer, G., Yarchoan, R. Wilson, W. (2003) Highly effective treatment of acquired immunodeficiency syndrome-related lymphoma with dose-adjusted EPOCH: impact of antiretroviral therapy suspension and tumor biology. Blood, 101, 4653 4659.
53. Marcus, R., Hodson, D., Coupland, S., Bessell, E., Mead, B. Pettitt, A.R. (2007) Guidelines on the diagnosis and management of adult patients with primary CNS lymphoma (PCNSL) and primary intra-ocular lymphoma (PIOL). WWW document. URL http://www.bcshguidelines.com/pdf/PCNSL-guidelines.pdf.
54. Mead, G., Barrans, S., Qian, W., Walewski, J., Radford, J., Wolf, M., Clawson, S., Stenning, S., Yule, C. Jack, A. (2008) A prospective clinicopathologic study of dose-modified CODOX-M/IVAC in patients with sporadic Burkitt lymphoma defined using cytogenetic and immunophenotypic criteria (MRC/NCRI LY10 trial). Blood, 112, 2248 2260.
55. Mentzer, S.J., Fingeroth, J., Reilly, J.J., Perrine, S.P. Faller, D.V. (1998) Arginine Butyrate-Induced Susceptibility to Ganciclovir in an Epstein-Barr-Virus-Associated Lymphoma. Blood Cells, Molecules, and Diseases, 24, 114 123.
56. Milpied, N., Vasseur, B., Parquet, N., Garnier, J.L., Antoine, C., Quartier, P., Carret, A.S., Bouscary, D., Faye, A., Bourbigot, B., Reguerre, Y., Stoppa, A.M., Bourquard, P., Hurault de Ligny, B., Dubief, F., Mathieu-Boue, A. Leblond, V. (2000) Humanized anti-CD20 monoclonal antibody (Rituximab) in post transplant B-lymphoproliferative disorder: a retrospective analysis on 32 patients. Annals of Oncology, 11 (Suppl 1 113 116.
57. Nabors, L.B., Palmer, C.A., Julian, B.A., Przekwas, A.M. Kew, C.E. (2009) Isolated Central Nervous System Posttransplant Lymphoproliferative Disorder Treated with High-Dose Intravenous Methotrexate. American Journal of Transplantation, 9, 1243 1248.
58. Oertel, S.H., Anagnostopoulos, I., Bechstein, W.O., Liehr, H. Riess, H.B. (2000) Treatment of posttransplant lymphoproliferative disorder with the anti-CD20 monoclonal antibody rituximab alone in an adult after liver transplantation: a new drug in therapy of patients with posttransplant lymphoproliferative disorder after solid organ transplantation? Transplantation, 69, 430 432.
59. Oertel, S., Papp-Váry, M., Anagnostopoulos, I., Hummel, M., Jonas, S. Riess, H. (2003) Salvage chemotherapy for refractory or relapsed post-transplant lymphoproliferative disorder in patients after solid organ transplantation with a combination of carboplatin and etoposide. British Journal of Haematology, 123, 830 835.
60. Oertel, S.H., Verschuuren, E., Reinke, P., Zeidler, K., Papp-Vary, M., Babel, N., Trappe, R.U., Jonas, S., Hummel, M., Anagnostopoulos, I., Dorken, B. Riess, H.B. (2005) Effect of anti-CD 20 antibody rituximab in patients with post-transplant lymphoproliferative disorder (PTLD). American Journal of Transplantation, 5, 2901 2906.
61. Orjuela, M., Gross, T.G., Cheung, Y.K., Alobeid, B., Morris, E. Cairo, M.S. (2003) A pilot study of chemoimmunotherapy (cyclophosphamide, prednisone, and rituximab) in patients with post-transplant lymphoproliferative disorder following solid organ transplantation. Clinical Cancer Research, 9, 3945S 3952S.
62. Paranjothi, S., Yusen, R.D., Kraus, M.D., Lynch, J.P., Patterson, G.A. Trulock, E.P. (2001) Lymphoproliferative disease after lung transplantation: comparison of presentation and outcome of early and late cases. Journal of Heart and Lung Transplantation, 20, 1054 1063.
63. Parker, A., Amlot, P., Bowles, K., Bradley, J.A., Emery, V., Featherstone, C., Gupte, G., Marcus, R., Parameshwar, J., Ramsay, A. Newstead, C. (2009) Guidelines on the Surveillance, Diagnosis and Management of Post-Transplant Lymphoproliferative Disorders in Adult Solid Organ Transplant Recipients. WWW document. URL. http://www.bcshguidelines.com/pdf/pltd- finaldraft-071009.pdf.
64. Paya, C.V., Fung, J.J., Nalesnik, M.A., Kieff, E., Green, M., Gores, G., Habermann, T.M., Wiesner, R.H., Swinnen, L.J., Woodle, E.S., Bromberg, J.S. for the ASTS/ASTP EBV-PTLD Task Force the Mayo Clinic organized International Consensus Development Meeting on Epstein Barr Virus-Induced Posttransplant Lymphoproliferative Disorders (PTLD) (1999) Epstein-Barr Virus-Induced Posttransplant Lymphoproliferative Disorders. Transplantation, 68, 1517 1525.
65. Penn, I. Porat, G. (1995) Central nervous system lymphomas in organ allograft recipients. Transplantation, 59, 240 244.
66. Perrine, S.P., Hermine, O., Small, T., Suarez, F., O'Reilly, R., Boulad, F., Fingeroth, J., Askin, M., Levy, A., Mentzer, S.J., Di Nicola, M., Gianni, A.M., Klein, C., Horwitz, S. Faller, D.V. (2007) A phase 1/2 trial of arginine butyrate and ganciclovir in patients with Epstein-Barr virus-associated lymphoid malignancies. Blood, 109, 2571 2578.
67. Pfreundschuh, M., Schubert, J., Ziepert, M., Schmits, R., Mohren, M., Lengfelder, E., Reiser, M., Nickenig, C., Clemens, M., Peter, N., Bokemeyer, C., Eimermacher, H., Ho, A., Hoffmann, M., Mertelsmann, R., Trümper, L., Balleisen, L., Liersch, R., Metzner, B., Hartmann, F., Glass, B., Poeschel, V., Schmitz, N., Ruebe, C., Feller, A. Loeffler, M. (2008) German High-Grade Non-Hodgkin Lymphoma Study Group (DSHNHL). Six versus eight cycles of bi-weekly CHOP-14 with or without rituximab in elderly patients with aggressive CD20+ B-cell lymphomas: a randomised controlled trial (RICOVER-60). Lancet Oncology, 9, 105 116.
68. Pham, P.T., Wilkinson, A.H., Gritsch, H.A., Pham, P.C., Miller, J.M., Lassman, C.R. Danovitch, G.M. (2002) Monotherapy with the anti-CD20 monoclonal antibody rituximab in a kidney transplant recipient with posttransplant lymphoproliferative disease. Transplantation Proceedings, 34, 1178 1181.
69. Pirsch, J., Stratta, R., Sollinger, H., Hafez, G., D'Alessandro, A., Kalayoglu, M. Belzer, F. (1989) Treatment of severe Epstein-Barr virus-induced lymphoproliferative syndrome with ganciclovir: two cases after solid organ transplantation. American Journal of Medicine, 86, 241 244.
70. Raj, R. Frost, A. (2005) Lung retransplantation after posttransplantation lymphoproliferative disorder (PTLD): a single-center experience and review of literature of PTLD in lung transplant recipients. Journal of Heart and Lung Transplantation, 24, 671 679.
71. Reams, B.D., McAdams, H.P., Howell, D.N., Steele, M.P., Davis, R.D. Palmer, S.M. (2003) Posttransplant lymphoproliferative disorder: incidence, presentation, and response to treatment in lung transplant recipients. Chest, 124, 1242 1249.
72. Savoldo, B., Goss, J.A., Hammer, M.M., Zhang, L., Lopez, T., Gee, A.P., Lin, Y.-F., Quiros-Tejeira, R.E., Reinke, P., Schubert, S., Gottschalk, S., Finegold, M.J., Brenner, M.K., Rooney, C.M. Heslop, H.E. (2006) Treatment of solid organ transplant recipients with autologous Epstein Barr virus-specific cytotoxic T lymphocytes (CTLs). Blood, 108, 2942 2949.
73. Smith, T.J., Khatcheressian, J., Lyman, G.H., Ozer, H., Armitage, J.O., Balducci, L., Bennett, C.L., Cantor, S.B., Crawford, J., Cross, S.J., Demetri, G., Desch, C.E., Pizzo, P.A., Schiffer, C.A., Schwartzberg, L., Somerfield, M.R., Somlo, G., Wade, J.C., Wade, J.L., Winn, R.J., Wozniak, A.J. Wolff, A.C. (2006) 2006 update of recommendations for the use of white blood cell growth factors: an evidence-based clinical practice guideline. Journal of Clinical Oncology, 24, 3187 3205.
74. Stephan, J.L., Le Deist, F., Blanche, S., Le Bidois, J., Peuchmaur, M., Lellouch-Tubiana, A., Hirn, M., Griscelli, C. Fischer, A. (1992) Treatment of central nervous system B lymphoproliferative syndrome by local infusion of a B cell-specific monoclonal antibody. Transplantation, 54, 246 249.
75. Swerdlow, S.H., Campo, E., Harris, N.L., Jaffe, E.S., Pileri, S.A., Stein, H., Thiele, J. Vardiman, J.W. (eds 2008) WHO Classification of Tumours of Haematopoietic and Lymphoid Tissues. IARC
76. Swinnen, L.J. (2001) Organ transplant-related lymphoma. Current Treatment Options in Oncology, 2, 301 308.
77. Swinnen, L., Leblanc, M., Grogan, T., Gordon, L., Stiff, P., Miller, A., Kasamon, Y., Miller, T. Fisher, R. (2008) Prospective study of sequential reduction in immunosuppression, interferon alpha-2B, and chemotherapy for posttransplantation lymphoproliferative disorder. Transplantation, 86, 215 222.
78. Taj, M.M., Messahel, B., Mycroft, J., Pritchard-Jones, K., Baker, A., Height, S., Hadzic, N. Pinkerton, C.R. (2008) Efficacy and tolerability of high-dose methotrexate in central nervous system positive or relapsed lymphoproliferative disease following liver transplant in children. British Journal of Haematology, 140, 191 196.
79. Taylor, A., Marcus, R. Bradley, J. (2005) Post-transplant lymphoproliferative disorders (PTLD) after solid organ transplantation. Critical Reviews in Oncology and Hematology, 56, 155.
80. Taylor, A.L., Bowles, K.M., Callaghan, C.J., Wimperis, J.Z., Grant, J.W., Marcus, R.E. Bradley, J.A. (2006) Anthracycline-based chemotherapy as first-line treatment in adults with malignant posttransplant lymphoproliferative disorder after solid organ transplantation. Transplantation, 82, 375 381.
81. Trappe, R.U., Choquet, S., Reinke, P., Dreyling, M., Mergenthaler, H.G., Jager, U., Kebelmann-Betzing, C., Jonas, S., Lehmkuhl, H., Anagnostopoulos, I., Leblond, V., Hetzer, R., Dorken, B., Riess, H. Oertel, S. (2007) Salvage therapy for relapsed posttransplant lymphoproliferative disorders (PTLD) with a second progression of PTLD after Upfront chemotherapy: the role of single-agent rituximab. Transplantation, 84, 1708 1712.
82. Tsai, D., Hardy, C., Tomaszewski, J., Kotloff, R., Oltoff, K., Somer, B., Schuster, S., Porter, D., Montone, K. Stadtmauer, E. (2001) Reduction in immunosuppression as initial therapy for posttransplant lymphoproliferative disorder: analysis of prognostic variables and long-term follow-up of 42 adult patients. Transplantation, 71, 1076 1088.
83. Tulpule, S., Mikhael, G., Kazmi, M., Nunan, T., Van Der Walt, J., Goldsmith, D. Fields, P. (2005) B Cell Post Transplant Lymphoproliferative Disorder Complicating Solid Organ Transplantation (B-PTLD):a Single Centre Review Reporting 1) Results with Chemo-Immunotherapy (CHOP/R) and 2) the Predictive Ability of FDG-PET Scanning To Correlate with Long Term Overall Survival. Blood (ASH Annual Meeting Abstracts), 106, 1500.
84. Vose, J.M., Bierman, P.J., Anderson, J.R., Weisenburger, D., Moravec, D.F., Sorensen, S., Hutchins, M., Dowling, M.D., Howe, D. Okerbloom, J. (1991) CHLVPP chemotherapy with involved-field irradiation for Hodgkin's disease: favorable results with acceptable toxicity. Journal of Clinical Oncology, 9, 1421 1425.
85. Webber, S.A. Naftel, D.C. (2006) Pediatric heart transplant study. Lymphoproliferative disorders after pediatric heart transplantation: a multi-institutional study. Lancet, 367, 233 239.
86. Williams, S.L., Hartline, C.B., Kushner, N.L., Harden, E.A., Bidanset, D.J., Drach, J.C., Townsend, L.B., Underwood, M.R., Biron, K.K. Kern, E.R. (2003) In Vitro Activities of Benzimidazole D- and L-Ribonucleosides against Herpesviruses. Antimicrobial Agents and Chemotherapy, 47, 2186 2192.
87. Wilson, W., Grossbard, M., Pittaluga, S., Cole, D., Pearson, D., Drbohlav, N., Steinberg, S., Little, R., Janik, J., Gutierrez, M., Raffeld, M., Staudt, L., Cheson, B., Longo, D., Harris, N., Jaffe, E., Chabner, B., Wittes, R. Balis, F. (2002) Dose-adjusted EPOCH chemotherapy for untreated large B-cell lymphomas: a pharmacodynamic approach with high efficacy. Blood, 99, 2685 2693.
88. Wotherspoon, A., Diss, T., Pan, L., Singh, N., Whelan, J. Isaacson, P. (1996) Low grade gastric B-cell lymphoma of mucosa associated lymphoid tissue in immunocompromised patients. Histopathology, 28, 129 134.
89. Zilz, N.D., Olson, L.J. McGregor, C.G. (2001) Treatment of post-transplant lymphoproliferative disorder with monoclonal CD20 antibody (rituximab) after heart transplantation. Journal of Heart and Lung Transplantation, 20, 770 772.